Imbio signs Heart&Lung Health in U.K.

By The Science Advisory Board staff writers

April 6, 2021 -- Artificial intelligence (AI) software developer Imbio has signed a deal with U.K. cardiothoracic radiology services provider Heart&Lung Health.

In a statement from Imbio, Heart&Lung Health said it would use Imbio's AI quantitative imaging algorithms in routine practice to augment reporting of computed tomography (CT) thorax studies in patients with potential lung diseases. Specifically, the software will be utilized to identify lung and cardiac conditions, according to Imbio.

Broad Institute launches new center with $150M endowment
The Broad Institute of the Massachusetts Institute of Technology and Harvard University have announced the launch of a new research center intended to...
Scientists connect gene to cancer metastasis for the first time
Researchers have identified new functionality of a previously underappreciated gene, leucine-rich repeat neuronal 4 C-terminal like (LRRN4CL), which is...
NanoString increases access to spatial molecular imager
NanoString Technologies has launched a technology access program for its spatial molecular imager.
ICR calls for votes in best imaging competition
The Institute of Cancer Research (ICR) in London is calling for public votes in its annual Science and Medical Imaging competition.
Preclinical lung imaging offers effective evaluation of drug candidates
Drug discovery and development are arduous and costly endeavors, with nine in 10 drug candidates failing to gain approval. Preclinical imaging can help...

Copyright © 2021

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter